1Brusson H,Benitez O,Uribe F,et al.Rotavirus-inhibitory activity in serial milk samples from Mexican women and rotavirus infections in their children during their first year of life[J].J Clin Microbiol,1993,31:593-597.
2Haffejee IE,Moosa A.Circulation and breast-milk anti-rotaviral antibodies and neonatal rotavirus infections:a maternal-neonatal study[J].Ann Trop Paediatr,1990,10:3-14.
4Genetsch JR, Woods PA, Ramacha dran M, et al. Review of G and P typing results from a global collection of rotavirus strain : implications for Vaccine development. J Infect Dis, 1996,174 (suppl) :S30-36.
5Santos N, Hoshino Y. Global distribution of rotavirus serotypts/genotypes and its implicatron for the development and implementation of an effective rotavieeine. Rev Med Virol,2005,15: 29-56.
6Eckmannl,Jung HC, Comelia SM,et al. Differential cytokine expression by human intestinal epithelial cell line; regulated expression of interleukin-8 Gastroenterology, 1993,48:133-138.
7Santos N, Volotao EM, Soares CC, et al. Predominance of rotavirus genotype G9 during the 1999,2000 and 2002 seasons among hospitalized children in the city of Salvado, Bakia, Brazil; implications for future vaccine strategies. J Chin Microaio1,2005 ,43 :4061-4069.
8Linhares AC, VerstractenT, Judith Wolleswinkel-van den Bosch, et al.Rotavirus Serotype Gq is associated with More severe Disease in Iatin American. CID ,2006,43 ( 3 ) :312-314.
9Salinas P, Perez S, Linhares AC, et al. Evalation of safety, immunogenicity and of an attenuated rotavirus vaccine RIX4414 :a randomized placeo-controlled trial in Latin American in fants. Pediatr infect Dis J,2005,24 : 804-817.
